Tert-Butylamine

Tert-Butylamine

SCHEMBL8148552

CC(=O)C[Si](C)(C)C.CC(C)(C)N

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEIDH1

The experimentally established mechanism targets of Tert-Butylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
TRPA1 O75762 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6526896 0.86
Tert-Butylamine SCHEMBL4062442 0.69
SCHEMBL28488688 0.67 ALDH1A1 (0.41) ALDH1A1TDP1TRPA1
SCHEMBL6675846 0.67 KMT2A (0.33)
Tert-Butylamine SCHEMBL289315 0.66
Tert-Butylamine SCHEMBL27717339 0.66 FFAR3 (0.58) ALDH1A1TDP1
SCHEMBL8330396 0.65 KDM4E (0.44) ALDH1A1TDP1TRPA1
Tert-Butylamine SCHEMBL29006209 0.64 FFAR3 (0.54) ALDH1A1TDP1
Tert-Butylamine SCHEMBL28603936 0.64
SCHEMBL29050923 0.64 ALDH1A1 (0.44) ALDH1A1TDP1TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6150421-A Treatment of estrogen-receptor positive breast cancer and estrogen-receptor negative breast cancer with retinoid with CH2 OH at the side chain terminal position CORNELL RESEARCH FOUNDATION, INC. (US) 2000-11-21 US disclosed